Search

Displaying results 2861 - 2870 of 8196 in total
  1. Drug

    Azathioprine

    go.drugbank.com/drugs/DB00993
    ApprovedInvestigational

    [A189678,A189687,A189690] Azathioprine is used to treat inflammatory conditions like rheumatoid arthritis and as an immunosuppressant in the prevention of renal transplant rejection. … Azathioprine is a prodrug of 6-mercaptopurine, first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings in an attempt to produce a derivative of 6-mercaptopurine with a better therapeutic

    Categories: Cytochrome P-450 Substrates, P-glycoprotein substratesProducts: Nu-azathioprine
  2. Drug

    Calendula officinalis flower

    go.drugbank.com/drugs/DB14263
    Approved

    It is not an approved drug.

  3. Drug

    Rumex crispus whole

    go.drugbank.com/drugs/DB14267
    Approved

    It is not an approved drug.

  4. Drug

    Ocimum tenuiflorum top

    go.drugbank.com/drugs/DB14273
    ApprovedWithdrawn

    It is not an approved drug.

  5. Drug

    Angelica archangelica root

    go.drugbank.com/drugs/DB14283
    Approved

    It is not an approved drug.

  6. Drug

    Kaempferia galanga root

    go.drugbank.com/drugs/DB14288
    ApprovedWithdrawn

    It is not an approved drug.

  7. Drug

    Inula helenium root

    go.drugbank.com/drugs/DB14350
    Approved

    It is not an approved drug.

    Synonyms: Tu Mu Xiang, Tu Mu Xiang Root
  8. Drug

    Paramethadione

    go.drugbank.com/drugs/DB00617
    Approved

    Paramethadione is an anticonvulsant in the oxazolidinedione class. It is associated with fetal trimethadione syndrome, which is also known as paramethadione syndrome.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C8 Substrates
  9. Drug

    Cupric Chloride

    go.drugbank.com/drugs/DB09131
    Approved

    Cupric chloride, for injection, is a sterile, nonpyrogenic solution intended for use as an additive to solutions for Total Parenteral Nutrition (TPN).

  10. Drug

    Olaratumab

    go.drugbank.com/drugs/DB06043
    ApprovedInvestigational

    Olaratumab (IMC-3G3) is a fully human IgG1 monoclonal antibody with antitumor activity that selectively binds the external domain of human platelet-derived growth factor receptor (PDGFR)-α with high affinity and blocks ligand binding. It...